KALIYAN BRYANT: Open Payments
NPI 1306421656 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 7 payments from 3 companies in 2025. Trend: 2023 $502 · 2024 $1,040 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 3 | $84 |
| Galderma Laboratories, L.P. | 2 | $41 |
| ABBVIE INC. | 2 | $32 |
Products named: Xeomin, QULIPTA.
Industry payments across CA — which companies pay providers there.
